Characterization of CCR5–/– apoE–/– and CCR1–/– apoE–/– mice
. | CCR5+/+ apoE-/- . | CCR5-/- apoE-/- . | P . | CCR1+/+ apoE-/- . | CCR1-/- apoE-/- . | P . |
---|---|---|---|---|---|---|
Neointimal area, μm2 | 17 894 ± 2 934 | 6 631 ± 1 026 | .005 | 10 414 ± 1 385 | 10 591 ± 1 886 | NS |
% EEL area | 32.3 ± 2.6 | 13.7 ± 2.2 | < .001 | 28.0 ± 2.9 | 27.9 ± 2.5 | NS |
Medial area, μm2 | 12 689 ± 1 162 | 11 696 ± 474 | NS | 14 608 ± 2 726 | 13 820 ± 1 487 | NS |
% EEL area | 26.0 ± 3.3 | 21.5 ± 1.8 | NS | 25.0 ± 2.9 | 23.5 ± 2.7 | NS |
Macrophage content, % neointimal area | 23.2 ± 7.0 | 5.8 ± 3.2 | .035 | 11.0 ± 7.6 | 13.7 ± 5.4 | NS |
SMC content, % neointimal area | 27.5 ± 3.7 | 61.7 ± 6.0 | .003 | 21.8 ± 3.7 | 37.5 ± 7.1 | NS |
T-cell content, % neointimal area | 15.3 ± 0.6 | 2.4 ± 1.0 | < .001 | 10.3 ± 2.0 | 6.4 ± 1.4 | NS |
IFN-γ content, % neointimal area | 2.0 ± 1.2 | 1.2 ± 1.2 | NS | 0.3 ± 0.3 | 6.7 ± 2.0 | .037 |
IL-10 content, % neointimal area | 13.6 ± 0.8 | 29.3 ± 4.1 | .020 | 10.3 ± 3.5 | 11.8 ± 2.4 | NS |
CD4+/IFN-γ+ cells, % splenocytes | 2.30 ± 0.12 | 1.53 ± 0.20 | .030 | 2.60 ± 0.30 | 2.84 ± 0.19 | NS |
CD4+/IL-10+ cells, % splenocytes | 0.58 ± 0.07 | 1.19 ± 0.18 | .036 | 0.86 ± 0.06 | 0.50 ± 0.06 | .008 |
Th1/Th2 index, IFN-γ+/IL-10+ | 4.0 | 1.3 | — | 3.1 | 5.7 | — |
. | CCR5+/+ apoE-/- . | CCR5-/- apoE-/- . | P . | CCR1+/+ apoE-/- . | CCR1-/- apoE-/- . | P . |
---|---|---|---|---|---|---|
Neointimal area, μm2 | 17 894 ± 2 934 | 6 631 ± 1 026 | .005 | 10 414 ± 1 385 | 10 591 ± 1 886 | NS |
% EEL area | 32.3 ± 2.6 | 13.7 ± 2.2 | < .001 | 28.0 ± 2.9 | 27.9 ± 2.5 | NS |
Medial area, μm2 | 12 689 ± 1 162 | 11 696 ± 474 | NS | 14 608 ± 2 726 | 13 820 ± 1 487 | NS |
% EEL area | 26.0 ± 3.3 | 21.5 ± 1.8 | NS | 25.0 ± 2.9 | 23.5 ± 2.7 | NS |
Macrophage content, % neointimal area | 23.2 ± 7.0 | 5.8 ± 3.2 | .035 | 11.0 ± 7.6 | 13.7 ± 5.4 | NS |
SMC content, % neointimal area | 27.5 ± 3.7 | 61.7 ± 6.0 | .003 | 21.8 ± 3.7 | 37.5 ± 7.1 | NS |
T-cell content, % neointimal area | 15.3 ± 0.6 | 2.4 ± 1.0 | < .001 | 10.3 ± 2.0 | 6.4 ± 1.4 | NS |
IFN-γ content, % neointimal area | 2.0 ± 1.2 | 1.2 ± 1.2 | NS | 0.3 ± 0.3 | 6.7 ± 2.0 | .037 |
IL-10 content, % neointimal area | 13.6 ± 0.8 | 29.3 ± 4.1 | .020 | 10.3 ± 3.5 | 11.8 ± 2.4 | NS |
CD4+/IFN-γ+ cells, % splenocytes | 2.30 ± 0.12 | 1.53 ± 0.20 | .030 | 2.60 ± 0.30 | 2.84 ± 0.19 | NS |
CD4+/IL-10+ cells, % splenocytes | 0.58 ± 0.07 | 1.19 ± 0.18 | .036 | 0.86 ± 0.06 | 0.50 ± 0.06 | .008 |
Th1/Th2 index, IFN-γ+/IL-10+ | 4.0 | 1.3 | — | 3.1 | 5.7 | — |
Data represent mean ± SEM.
EEL indicates external elastic lamina; NS, not significant;—, not applicable.